This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (45)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Adolescent Medicine  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Delia Scholes, PhD; Andrea Z. LaCroix, PhD; Laura E. Ichikawa, MS; William E. Barlow, PhD; Susan M. Ott, MD

Arch Pediatr Adolesc Med. 2005;159:139-144.

Background  Several studies report an association between depot medroxyprogesterone acetate (DMPA) injectable contraception and decreased bone mineral density. Adolescents, who are still gaining bone, may be particularly affected, but there has been little study of the association in adolescent users and none following discontinuation.

Objective  To evaluate bone mineral density changes in adolescents using and discontinuing use of DMPA contraception.

Design  A population-based prospective cohort study.

Participants  One hundred seventy adolescent women, aged 14 to 18 years; 80 baseline DMPA users and 90 age-similar, unexposed comparison women. Sixty-one participants discontinued DMPA use during follow-up.

Main Outcome Measure  Bone mineral density, measured every 6 months for 24 to 36 months at the hip, spine, and whole body, comparing mean bone mineral density changes in DMPA users and discontinuers with nonusers.

Results  Among DMPA users, bone mineral density declined significantly relative to nonusers at the hip and spine but not the whole body. Annualized mean percentage changes, adjusted for covariates, were hip, –1.81% vs –0.19%; P<.001; spine, –0.97% vs 1.32%; P<.001, and whole body, 0.73% vs 0.88%; P = .78 for DMPA users vs nonusers, respectively. New users lost bone mineral density more rapidly than prevalent users. Discontinuers experienced significantly increased bone mineral density relative to nonusers at all anatomical sites; annualized mean percentage changes were hip, 1.34% vs –0.19%; P = .004; spine, 2.86% vs 1.32%; P = .004; and whole body, 3.56% vs 0.88%; P<.001.

Conclusions  Use of DMPA contraception in adolescents was associated with significant continuous losses of bone mineral density at the hip and spine. However, significant gains postdiscontinuation provide evidence that the loss of bone mass is apparently reversed.

Author Affiliations: Center for Health Studies, Group Health Cooperative, Seattle, Wash (Drs Scholes, LaCroix, and Barlow and Ms Ichikawa); Departments of Epidemiology (Drs Scholes and LaCroix) and Biostatistics (Dr Barlow), School of Public Health and Community Medicine, Department of Medicine (Dr Ott), School of Medicine, University of Washington, Seattle; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle (Dr LaCroix); Cancer Research and Biostatistics, Seattle (Dr Barlow).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Osteoporosis in a young woman after 6 years of levonorgestrel administration from intrauterine devices?
Greiner et al.
BMJ Case Reports 2009;2009:bcr0720080484-bcr0720080484.
ABSTRACT | FULL TEXT  

Contraception in women with medical problems
Dhanjal
Obstet Med 2008;1:78-87.
ABSTRACT | FULL TEXT  

Reproductive Hormones and Skeletal Health in Young Women
Ott
J. Clin. Endocrinol. Metab. 2008;93:1175-1177.
FULL TEXT  

Effects of Depot Medroxyprogesterone Acetate on Bone Density and Bone Metabolism before and after Peak Bone Mass: A Case-Control Study
Walsh et al.
J. Clin. Endocrinol. Metab. 2008;93:1317-1323.
ABSTRACT | FULL TEXT  

Contraception and Adolescents
Committee on Adolescence
Pediatrics 2007;120:1135-1148.
ABSTRACT | FULL TEXT  

Suppression of menstruation in adolescents with severe learning disabilities
Albanese and Hopper
Arch. Dis. Child. 2007;92:629-632.
ABSTRACT | FULL TEXT  

Contraception in Canada: a review of method choices, characteristics, adherence and approaches to counselling
Fisher and Black
CMAJ 2007;176:953-961.
ABSTRACT | FULL TEXT  

Adolescent bone health.
Loud and Gordon
Arch Pediatr Adolesc Med 2006;160:1026-1032.
ABSTRACT | FULL TEXT  

Long-Acting Methods of Contraception
Greenberg et al.
NEJM 2006;354:645-646.
FULL TEXT  

Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain
Crosignani et al.
Hum Reprod 2006;21:248-256.
ABSTRACT | FULL TEXT  

Bone Mineral Density and Depot Medroxyprogesterone Acetate Contraception
Brookman
AAP Grand Rounds 2005;13:68-69.
FULL TEXT  

Teens Regain BMD After Stopping Depo-Provera
JWatch Women's Health 2005;2005:3-3.
FULL TEXT